189 related articles for article (PubMed ID: 29930251)
1. Treponema denticola chymotrypsin-like protease as associated with HPV-negative oropharyngeal squamous cell carcinoma.
Kylmä AK; Jouhi L; Listyarifah D; Mohamed H; Mäkitie A; Remes SM; Haglund C; Atula T; Nieminen MT; Sorsa T; Hagström J
Br J Cancer; 2018 Jul; 119(1):89-95. PubMed ID: 29930251
[TBL] [Abstract][Full Text] [Related]
2. In HPV-negative oropharyngeal squamous cell carcinoma, elevated toll-like receptor 2 immunoexpression may increase the risk of disease-specific mortality.
Kylmä AK; Jouhi L; Mohamed H; Randén-Brady R; Mäkitie A; Atula T; Haglund C; Sorsa T; Hagström J
Oral Oncol; 2020 Aug; 107():104778. PubMed ID: 32403078
[TBL] [Abstract][Full Text] [Related]
3. Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma.
Kylmä AK; Tolvanen TA; Carpén T; Haglund C; Mäkitie A; Mattila PS; Grenman R; Jouhi L; Sorsa T; Lehtonen S; Hagström J
Exp Mol Pathol; 2020 Jun; 114():104435. PubMed ID: 32240617
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients.
Jouhi L; Mohamed H; Mäkitie A; Remes SM; Haglund C; Atula T; Hagström J
Cancer Immunol Immunother; 2017 Dec; 66(12):1619-1629. PubMed ID: 28856441
[TBL] [Abstract][Full Text] [Related]
5. Treponema denticola chymotrypsin-like proteinase is present in early-stage mobile tongue squamous cell carcinoma and related to the clinicopathological features.
Listyarifah D; Nieminen MT; Mäkinen LK; Haglund C; Grenier D; Häyry V; Nordström D; Hernandez M; Yucel-Lindberg T; Tervahartiala T; Ainola M; Sorsa T; Hagström J
J Oral Pathol Med; 2018 Sep; 47(8):764-772. PubMed ID: 29747237
[TBL] [Abstract][Full Text] [Related]
6. Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive carcinogenesis through immunomodulation.
Nieminen MT; Listyarifah D; Hagström J; Haglund C; Grenier D; Nordström D; Uitto VJ; Hernandez M; Yucel-Lindberg T; Tervahartiala T; Ainola M; Sorsa T
Br J Cancer; 2018 Feb; 118(3):428-434. PubMed ID: 29149107
[TBL] [Abstract][Full Text] [Related]
7. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Role of
Kylmä AK; Sorsa T; Jouhi L; Mustonen HK; Mohamed H; Randén-Brady R; Mäkitie A; Atula T; Hagström J; Haglund C
Anticancer Res; 2022 Nov; 42(11):5415-5430. PubMed ID: 36288857
[TBL] [Abstract][Full Text] [Related]
9. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
Jouhi L; Datta N; Renkonen S; Atula T; Mäkitie A; Haglund C; Ahmed A; Syrjänen S; Grénman R; Auvinen E; Lehtonen S; Hagström J
Tumour Biol; 2015 Sep; 36(10):7755-64. PubMed ID: 25941114
[TBL] [Abstract][Full Text] [Related]
10. Expression of cell cycle-related proteins in oropharyngeal squamous cell carcinoma based on human papilloma virus status.
Tsuchida K; Sugai T; Uesugi N; Ishida K; Matsuura K; Sato I; Shiga K; Sato H
Oncol Rep; 2017 Aug; 38(2):908-916. PubMed ID: 28627689
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinomas.
Biron VL; Mohamed A; Hendzel MJ; Alan Underhill D; Seikaly H
J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S65-70. PubMed ID: 22569052
[TBL] [Abstract][Full Text] [Related]
12. DNA-Pk
Weaver AN; Cooper TS; Wei S; Carroll WR; Rosenthal EL; Yang ES
Head Neck; 2017 Feb; 39(2):206-214. PubMed ID: 27507640
[TBL] [Abstract][Full Text] [Related]
13. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.
van Kempen PM; van Bockel L; Braunius WW; Moelans CB; van Olst M; de Jong R; Stegeman I; van Diest PJ; Grolman W; Willems SM
Cancer Med; 2014 Oct; 3(5):1185-96. PubMed ID: 25065733
[TBL] [Abstract][Full Text] [Related]
14. RNA Oncoimmune Phenotyping of HPV-Positive p16-Positive Oropharyngeal Squamous Cell Carcinomas by Nodal Status.
Stepp WH; Farquhar D; Sheth S; Mazul A; Mamdani M; Hackman TG; Hayes DN; Zevallos JP
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):967-975. PubMed ID: 29710215
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition in human papillomavirus-positive and -negative oropharyngeal squamous cell carcinoma.
Hatakeyama H; Mizumachi T; Sakashita T; Kano S; Homma A; Fukuda S
Oncol Rep; 2014 Dec; 32(6):2673-9. PubMed ID: 25241968
[TBL] [Abstract][Full Text] [Related]
16. Mutation patterns in recurrent and/or metastatic oropharyngeal squamous cell carcinomas in relation to human papillomavirus status.
Reder H; Wagner S; Wuerdemann N; Langer C; Sandmann S; Braeuninger A; Dugas M; Gattenloehner S; Wittekindt C; Klussmann JP
Cancer Med; 2021 Feb; 10(4):1347-1356. PubMed ID: 33527763
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis.
Huebbers CU; Verhees F; Poluschkin L; Olthof NC; Kolligs J; Siefer OG; Henfling M; Ramaekers FCS; Preuss SF; Beutner D; Seehawer J; Drebber U; Korkmaz Y; Lam WL; Vucic EA; Kremer B; Klussmann JP; Speel EM
Int J Cancer; 2019 May; 144(10):2465-2477. PubMed ID: 30367463
[TBL] [Abstract][Full Text] [Related]
19. High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-status.
Kumar B; Brown NV; Swanson BJ; Schmitt AC; Old M; Ozer E; Agrawal A; Schuller DE; Teknos TN; Kumar P
Oncotarget; 2016 Apr; 7(14):18665-77. PubMed ID: 26919244
[TBL] [Abstract][Full Text] [Related]
20. Whole genome sequencing reveals complexity in both HPV sequences present and HPV integrations in HPV-positive oropharyngeal squamous cell carcinomas.
Gao G; Wang J; Kasperbauer JL; Tombers NM; Teng F; Gou H; Zhao Y; Bao Z; Smith DI
BMC Cancer; 2019 Apr; 19(1):352. PubMed ID: 30975103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
